Rasburicase-induced hemolytic anemia in previously undiagnosed G6PD deficiency

Blood. 2018 Aug 9;132(6):673. doi: 10.1182/blood-2018-04-842724.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anemia, Hemolytic / chemically induced*
  • Anemia, Hemolytic / etiology
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Genetic Predisposition to Disease
  • Glucosephosphate Dehydrogenase Deficiency / complications
  • Glucosephosphate Dehydrogenase Deficiency / diagnosis*
  • Glucosephosphate Dehydrogenase Deficiency / genetics
  • Humans
  • Male
  • Methemoglobinemia / chemically induced*
  • Methemoglobinemia / etiology
  • Middle Aged
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Tumor Lysis Syndrome / drug therapy
  • Urate Oxidase / adverse effects*

Substances

  • Antineoplastic Agents
  • rasburicase
  • Urate Oxidase

Supplementary concepts

  • Lymphoblastic Leukemia, Acute, with Lymphomatous Features